AN1 0.00% 0.7¢ anagenics limited

Research: Midkine Controls Arteriogenesis by Regulating VEGFA Bioavailability and NOS Expression, page-2

  1. 551 Posts.
    lightbulb Created with Sketch. 173
    Similarly, in a related context:

    Involvement of Endothelial Nitric Oxide Synthase Activation in Midkine-Mediated Central Hypotensive Effects.

    "...In this study, the data showed that MK might play a role in central cardiovascular regulation in the NTS. These results suggest that MK decreased BP and HR in the NTS probably acting via the NMDA receptor-calmodulin-eNOS signaling pathway."

    Source: https://www.ncbi.nlm.nih.gov/pubmed/29241309/

    From December 2017
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $3.229M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $350 50K

Buyers (Bids)

No. Vol. Price($)
4 775527 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 5022 1
View Market Depth
Last trade - 11.14am 09/08/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.